Marcel Mueller

915 total citations
9 papers, 800 citations indexed

About

Marcel Mueller is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Marcel Mueller has authored 9 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Marcel Mueller's work include HER2/EGFR in Cancer Research (3 papers), Quinazolinone synthesis and applications (2 papers) and RNA and protein synthesis mechanisms (2 papers). Marcel Mueller is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Quinazolinone synthesis and applications (2 papers) and RNA and protein synthesis mechanisms (2 papers). Marcel Mueller collaborates with scholars based in Switzerland, Germany and South Korea. Marcel Mueller's co-authors include Helmut Mett, Elisabeth Buchdunger, Thomas Meyer, Hynes Ne, Winfried S. Wels, Bernd Groner, Urs Regenass, Peter Traxler, Nicholas Lydon and Pascal Furet and has published in prestigious journals such as Nucleic Acids Research, Journal of Medicinal Chemistry and Acta Physiologica.

In The Last Decade

Marcel Mueller

9 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcel Mueller Switzerland	8	408	209	189	170	113	9	800
K. Ulrich Wendt Germany	18	662 1.6×	167 0.8×	246 1.3×	91 0.5×	51 0.5×	29	1.0k
Benjamin R. Bowen United States	18	875 2.1×	239 1.1×	112 0.6×	143 0.8×	157 1.4×	25	1.2k
Mark Humphrey United States	9	835 2.0×	332 1.6×	606 3.2×	97 0.6×	58 0.5×	10	1.5k
Nathan C. Ihle United States	14	283 0.7×	416 2.0×	311 1.6×	311 1.8×	78 0.7×	21	959
Miljenko Mervič United States	11	863 2.1×	141 0.7×	241 1.3×	224 1.3×	147 1.3×	16	1.3k
Scott Jakes United States	23	1.0k 2.5×	202 1.0×	267 1.4×	186 1.1×	327 2.9×	29	1.6k
Chu‐Biao Xue United States	22	577 1.4×	320 1.5×	197 1.0×	57 0.3×	38 0.3×	52	1.0k
Mary Gregoriou United Kingdom	15	465 1.1×	169 0.8×	128 0.7×	128 0.8×	42 0.4×	30	675
Zenon Konteatis United States	15	652 1.6×	48 0.2×	204 1.1×	154 0.9×	323 2.9×	28	1.1k
Hirokazu Iida Japan	17	339 0.8×	321 1.5×	97 0.5×	34 0.2×	96 0.8×	57	900

Countries citing papers authored by Marcel Mueller

Since Specialization

Citations

This map shows the geographic impact of Marcel Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Mueller more than expected).

Fields of papers citing papers by Marcel Mueller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Mueller. The network helps show where Marcel Mueller may publish in the future.

Co-authorship network of co-authors of Marcel Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Mueller. A scholar is included among the top collaborators of Marcel Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Mueller. Marcel Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Mueller, Marcel, et al.. (2020). Do the P1 and P2 hairpins of the Guanidine-II riboswitch interact?. Nucleic Acids Research. 48(18). 10518–10526. 17 indexed citations

2.

Persson, Pontus B. & Marcel Mueller. (2015). Transcription. Acta Physiologica. 215(4). 159–160. 1 indexed citations

3.

Traxler, Peter, Guido Bold, Marc Lang, et al.. (1997). Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines. Journal of Medicinal Chemistry. 40(22). 3601–3616. 185 indexed citations

4.

Begemann, Martin, Sungpyo Kim, Gregory J. Duigou, et al.. (1996). Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.. PubMed. 2(6). 1017–30. 23 indexed citations

5.

Traxler, Peter, Uwe Trinks, Elisabeth Buchdunger, et al.. (1995). [(Alkylamino)methyl]acrylophenones: Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase. Journal of Medicinal Chemistry. 38(13). 2441–2448. 72 indexed citations

6.

Trinks, Uwe, Elisabeth Buchdunger, Pascal Furet, et al.. (1994). Dianilinophthalimides: Potent and Selective, ATP-Competitive Inhibitors of the EGF-Receptor Protein Tyrosine Kinase. Journal of Medicinal Chemistry. 37(7). 1015–1027. 74 indexed citations

7.

Regenass, Urs, et al.. (1994). CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.. PubMed. 54(12). 3210–7. 96 indexed citations

8.

Alig, Leo, Paul Hadváry, Dietmar Knopp, et al.. (1992). Low molecular weight, non-peptide fibrinogen receptor antagonists. Journal of Medicinal Chemistry. 35(23). 4393–4407. 169 indexed citations

9.

Wels, Winfried S., et al.. (1992). Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor.. PubMed. 52(22). 6310–7. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact